News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
719,540 Results
Type
Article (66862)
Company Profile (222)
Press Release (652456)
Section
Business (192693)
Career Advice (2833)
Deals (35392)
Drug Delivery (115)
Drug Development (86999)
Employer Resources (164)
FDA (16767)
Job Trends (15113)
News (340483)
Policy (33401)
Tag
2024 BioCapital Digital (5)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (6)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (14)
2024 Biotech Beach Digital (7)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (6)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (3)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2879)
Academic (2)
Accelerated approval (3)
Adcomms (29)
Allergies (88)
Alliances (48916)
ALS (93)
Alzheimer's disease (1443)
Antibody-drug conjugate (ADC) (137)
Approvals (16738)
Artificial intelligence (255)
Autoimmune disease (19)
Automation (13)
Bankruptcy (322)
Best Places to Work (11823)
BIOSECURE Act (19)
Biosimilars (109)
Biotechnology (161)
Bladder cancer (65)
Brain cancer (29)
Breast cancer (271)
Cancer (2153)
Cardiovascular disease (182)
Career advice (2387)
Career pathing (32)
CAR-T (158)
Cell therapy (436)
Cervical cancer (20)
Clinical research (70256)
Collaboration (813)
Compensation (391)
Complete response letters (30)
COVID-19 (2722)
CRISPR (41)
C-suite (229)
Cystic fibrosis (104)
Data (2002)
Decentralized trials (2)
Denatured (28)
Depression (50)
Diabetes (261)
Diagnostics (6638)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (42)
Drug discovery (121)
Drug pricing (119)
Drug shortages (29)
Duchenne muscular dystrophy (91)
Earnings (70696)
Editorial (36)
Employer branding (19)
Employer resources (142)
Events (111376)
Executive appointments (674)
FDA (17926)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (726)
Gene editing (108)
Generative AI (22)
Gene therapy (312)
GLP-1 (762)
Government (4847)
Grass and pollen (5)
Guidances (47)
Healthcare (19937)
Huntington's disease (22)
IgA nephropathy (26)
Immunology and inflammation (126)
Indications (26)
Infectious disease (2865)
Inflammatory bowel disease (146)
Inflation Reduction Act (10)
Influenza (50)
Intellectual property (91)
Interviews (537)
IPO (16468)
IRA (49)
Job creations (3728)
Job search strategy (2012)
Kidney cancer (10)
Labor market (29)
Layoffs (512)
Leadership (18)
Legal (7430)
Liver cancer (76)
Lung cancer (314)
Lymphoma (139)
Machine learning (4)
Management (58)
Manufacturing (270)
MASH (68)
Medical device (13662)
Medtech (13667)
Mergers & acquisitions (19444)
Metabolic disorders (683)
Multiple sclerosis (73)
NASH (22)
Neurodegenerative disease (91)
Neuropsychiatric disorders (29)
Neuroscience (1963)
NextGen: Class of 2025 (6992)
Non-profit (4878)
Northern California (2379)
Now hiring (14)
Obesity (364)
Opinion (254)
Ovarian cancer (75)
Pain (87)
Pancreatic cancer (79)
Parkinson's disease (142)
Partnered (20)
Patents (215)
Patient recruitment (97)
Peanut (51)
People (60537)
Pharmaceutical (50)
Pharmacy benefit managers (20)
Phase I (21718)
Phase II (30706)
Phase III (22992)
Pipeline (1070)
Podcasts (78)
Policy (124)
Postmarket research (3124)
Preclinical (9462)
Press Release (67)
Prostate cancer (99)
Psychedelics (38)
Radiopharmaceuticals (263)
Rare diseases (393)
Real estate (6421)
Recruiting (65)
Regulatory (23231)
Reports (35)
Research institute (2539)
Resumes & cover letters (431)
Rett syndrome (3)
RNA editing (4)
RSV (45)
Schizophrenia (72)
Series A (128)
Series B (82)
Service/supplier (10)
Sickle cell disease (56)
Southern California (2099)
Special edition (16)
Spinal muscular atrophy (157)
Sponsored (28)
Startups (3595)
State (2)
Stomach cancer (16)
Supply chain (56)
The Weekly (48)
United States (21255)
Vaccines (722)
Venture capitalists (31)
Webinars (12)
Weight loss (254)
Women's health (34)
Worklife (17)
Date
Today (192)
Last 7 days (709)
Last 30 days (2859)
Last 365 days (34397)
2025 (8329)
2024 (35816)
2023 (40534)
2022 (51612)
2021 (56393)
2020 (55247)
2019 (48770)
2018 (37060)
2017 (33813)
2016 (33396)
2015 (39129)
2014 (32278)
2013 (28282)
2012 (29971)
2011 (30083)
2010 (29101)
Location
Africa (953)
Alabama (52)
Alaska (7)
Arizona (196)
Arkansas (14)
Asia (42236)
Australia (7467)
California (5480)
Canada (1840)
China (498)
Colorado (249)
Connecticut (268)
Delaware (130)
Europe (97911)
Florida (818)
Georgia (195)
Idaho (59)
Illinois (538)
India (23)
Indiana (295)
Iowa (7)
Japan (142)
Kansas (100)
Kentucky (24)
Louisiana (9)
Maine (67)
Maryland (850)
Massachusetts (4156)
Michigan (214)
Minnesota (365)
Mississippi (2)
Missouri (83)
Montana (31)
Nebraska (23)
Nevada (56)
New Hampshire (68)
New Jersey (1608)
New Mexico (30)
New York (1612)
North Carolina (976)
North Dakota (8)
Northern California (2379)
Ohio (185)
Oklahoma (15)
Oregon (36)
Pennsylvania (1175)
Puerto Rico (9)
Rhode Island (24)
South America (1325)
South Carolina (19)
South Dakota (1)
Southern California (2099)
Tennessee (92)
Texas (834)
Utah (165)
Virginia (133)
Washington D.C. (59)
Washington State (510)
West Virginia (3)
Wisconsin (54)
719,540 Results for "cancer treatment centers of america ctca".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America
March 17, 2025
·
11 min read
Press Releases
Anixa Biosciences’ Breast Cancer Vaccine was Featured on Fox News’ “America Reports”
February 25, 2025
·
4 min read
Press Releases
SignaBlok to Present Preclinical Data on TREM-1-Targeting Drug for the Treatment of Cancer at the American Association for Cancer Research (AACR) Annual Meeting 2025
March 18, 2025
·
1 min read
Press Releases
Aprea Therapeutics Announces Agreement with MD Anderson Cancer Center to Explore APR-1051 as a Potential Treatment for Head and Neck Squamous Cell Carcinoma (HNSCC)
March 11, 2025
·
6 min read
Press Releases
Nikon Instruments Announces Moffitt Cancer Center As Newest Nikon Center of Excellence
March 5, 2025
·
2 min read
Business
Galapagos Partners with Blood Centers of America to Decentralize CAR-T Production
Belgian biotech Galapagos is teaming with Blood Centers of America to help deploy its decentralized CAR-T therapy manufacturing platform closer to treatment centers across the U.S.
May 16, 2024
·
2 min read
·
Tristan Manalac
Press Releases
TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
February 27, 2025
·
14 min read
Press Releases
National Cancer Center Japan and PeptiDream: New Radiopharmaceuticals for Renal Cell Carcinoma
March 31, 2025
·
10 min read
Press Releases
Ruvidar Effective in the Treatment of Herpes
Ruvidar(TM) demonstrates higher efficacy in the treatment of Herpes Simplex Virus, Type 1 versus the standard of care treatments Acyclovir and Abreva in a preclinical animal model.
March 24, 2025
·
9 min read
Press Releases
Akeso’s Penpulimab Receives NMPA Approval for First-Line Treatment of Nasopharyngeal Cancer
March 17, 2025
·
3 min read
1 of 71,954
Next
